Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...
Firm debuts with an oversubscribed Fund I backed by 100+ LPs; opens waiting list for Fund II MANCHESTER, N.H.--(BUSINESS WIRE)--January 6, 2026-- Pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback